Related Articles
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide
Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38‑MAPK signaling pathway
Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts
N-(4-HYDROXYPHENYL)RETINAMIDE INDUCES APOPTOSIS IN HUMAN LEUKEMIA HL-60 CELLS AND MEDIATES VIMENTIN DOWN-REGULATION
Pleiotropic effects of fenretinide in neuroblastoma cell lines and multicellular tumor spheroids